India To Keep Closer Eye On Clinical Trials To Identify Mortality Causes
This article was originally published in PharmAsia News
Executive Summary
Clinical drug trials in India are to be monitored by health authorities for mortality rates in response to a World Health Organization report that Indian trials averaged more than one death per day.